Brent C. James, MD
Weighing the risks and benefits of any treatment to decide whether it is worth pursuing takes a kind of knowledge that most in health care lack
Evidence Review
A summary of the ECRI Institute’s Emerging Technology Evidence Report
Legislation & Regulation
John Carroll
However, they’ll need to prove it. Powerful interest groups say insurers have little experience with these patients and worry that MCOs will shortchange members.
Plan Watch
Frank Diamond
Healthy Blue Living in Michigan lets employers and members reap the benefits of lifestyle improvement
Tomorrow's Medicine
Thomas Morrow, MD
Clinicians can consider this radiotherapy a viable treatment option
News & Commentary

A blueprint for high-volume, high-quality lung cancer screening that is detecting cancer earlier—and helping to save lives

Clinical Brief

Multiple Sclerosis: New Perspectives on the Patient Journey–2019 Update
Summary of an Actuarial Analysis and Report